Search

Your search keyword '"Fluoroquinolones toxicity"' showing total 269 results

Search Constraints

Start Over You searched for: Descriptor "Fluoroquinolones toxicity" Remove constraint Descriptor: "Fluoroquinolones toxicity"
269 results on '"Fluoroquinolones toxicity"'

Search Results

1. The Use of Aquatic Macrophytes as a Nature-Based Solution to Prevent Ciprofloxacin Deleterious Effects on Microalgae.

2. Intra-species differences shape differences of enrofloxacin residues and its degradation products in tilapia: A precise risk assessment.

3. Long-term toxicity of fluoroquinolones: a comprehensive review.

4. Solar Photodegradation of a Novel des-F(6)-Fluoroquinolone, Garenoxacin, and Ecotoxicity of Its Phototransformation Products.

5. Induction of the mitochondrial pathway of apoptosis by enrofloxacin in the context of the safety issue of its use in poultry.

6. The Use of Aquatic Macrophytes as a Nature-Based Solution to Prevent Ciprofloxacin Deleterious Effects on Microalgae

7. Laccase mediated transformation of fluoroquinolone antibiotics: Analyzing degradation pathways and assessing algal toxicity.

8. Reactive metabolite of trovafloxacin activates inflammasomes: Implications for trovafloxacin-induced liver injury.

9. Identifying and Predicting Delayed Mortality with Toxicokinetic-Toxicodynamic Models.

10. Ecotoxicity of the fluoroquinolone antibiotic delafloxacin to the water flea Simocephalus vetulus and its offspring under the influence of calcium modulation.

11. How Should We Activate Ferrate(VI)? Fe(IV) and Fe(V) Tell Different Stories about Fluoroquinolone Transformation and Toxicity Changes.

12. Pharmacokinetic model of human exposure to ciprofloxacin through consumption of fish.

13. Long-term exposure of Allonais inaequalis to a mixture of antibiotics in freshwater and synthetic wastewater matrices: Reproduction, recovery, and swimming responses.

14. Inhibition of algal blooms by residual antibiotics in aquatic environments: Design, screening, and validation of antibiotic alternatives.

15. The Use of Aquatic Macrophytes as a Nature-Based Solution to Prevent Ciprofloxacin Deleterious Effects on Microalgae

16. An optimized electro-fenton pretreatment for the degradation and mineralization of a mixture of ofloxacin, norfloxacin, and ciprofloxacin.

17. Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model.

18. Occurrence, distribution and risk assessment of antibiotics at various aquaculture stages in typical aquaculture areas surrounding the Yellow Sea.

19. Comprehensive understanding of fluoroquinolone degradation via MPUV/PAA process: Radical chemistry, matrix effects, degradation pathways, and toxicity.

20. Designing benign molecules: The influence of O-acetylated glucosamine-substituents on the environmental biodegradability of fluoroquinolones.

21. Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues.

22. Determinants of the exposure of Eurasian griffon vultures (Gyps fulvus) to fluoroquinolones used in livestock: The role of supplementary feeding stations.

23. Efficient and synergistic degradation of fluoroquinolones by bacteria and microalgae: Design of environmentally friendly substitutes, risk regulation and mechanism analysis.

24. Ecotoxicological effects of human and veterinary antibiotics on water flea (Daphnia magna).

25. Toxicity, biodegradation of moxifloxacin and gatifloxacin on Chlamydomonas reinhardtii and their metabolic fate.

26. Magnetic visible-light activated photocatalyst ZnFe 2 O 4 /BiVO 4 /g-C 3 N 4 for decomposition of antibiotic lomefloxacin: Photocatalytic mechanism, degradation pathway, and toxicity assessment.

27. Fluoroquinolone antibiotics disturb the defense system, gut microbiome, and antibiotic resistance genes of Enchytraeus crypticus.

28. Photodegradation of fluoroquinolones in aqueous solution under light conditions relevant to surface waters, toxicity assessment of photoproduct mixtures.

29. Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics.

30. Delayed toxicity of three fluoroquinolones and their mixtures after neonatal or embryonic exposure, in Daphnia magna.

31. Toxicity of fluoroquinolones on the cladoceran Daphnia magna.

32. Pan-HDAC (Histone Deacetylase) Inhibitors Increase Susceptibility of Thoracic Aortic Aneurysm and Dissection in Mice.

33. Toxicity induced by ciprofloxacin and enrofloxacin: oxidative stress and metabolism.

34. TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.

35. Responses of Cirrhinus mrigala to second-generation fluoroquinolone (ciprofloxacin) toxicity: Assessment of antioxidants, tissue morphology, and inorganic ions.

36. In vitro toxicity evaluation of lomefloxacin-loaded MCM-41 mesoporous silica nanoparticles.

37. An adjusted 3D-QSAR model for the combined activity of fluoroquinolones photodegradation and microbial degradation assisted by dynamic simulation and its application in molecular modification.

38. Fluoroquinolone exposure in utero did not affect articular cartilage of resulting foals.

39. Cytotoxicity and antigenotoxicity evaluation of acetylshikonin and shikonin.

40. Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

41. Fluoroquinolone-contaminated poultry litter strongly affects earthworms as verified through lethal and sub-lethal evaluations.

42. Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.

43. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.

44. Highly biodegradable fluoroquinolone derivatives designed using the 3D-QSAR model and biodegradation pathways analysis.

45. A Double-Activity (Green Algae Toxicity and Bacterial Genotoxicity) 3D-QSAR Model Based on the Comprehensive Index Method and Its Application in Fluoroquinolones' Modification.

46. Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.

47. Environmental Conversion Path Inference of New Designed Fluoroquinolones and Their Potential Environmental Risk.

48. Reproductive toxicity of fluoroquinolones in birds.

49. Effects of TNFR1 gene silencing on early apoptosis of marbofloxacin-treated chondrocytes from juvenile dogs.

50. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.

Catalog

Books, media, physical & digital resources